Health and Healthcare

Can A Genentech Upgrade Fix Its Woes? (DNA)

This morning shares of Genentech (DNA-NYSE) are trading up 1.3% at just under $76.00 after a Deutsche Bank upgrade on the stock.  Shares closed at $74.90 yesterday and even traded as low as $74.32 intraday.  Both levels marked lows for the last 52-weeks, but this is actually a critical juncture because the stock broke a two-year low since their was no ‘wow-effect’ at all this year from teh ASCO conference last weekend.

The Deutsche Bank upgrade this morning from a ‘Hold’ to ‘Buy’ is based on discount valuations and upon treatments for colon cancer, MS, and lupus.  The 12-month target is somewhat in-line with many of the older ‘buy’ targets from Wall Street and is listed as $95.00. 

With Congress looking for ways to scalp biotech drug prices, with an election coming up, and with a chart that is looking like a weak pulse in the ICU one just has to wonder if this upgrade will really change much.  Stocks that trade at a discount usually do so for a reason.

Jon C. Ogg
June 8, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Is Your Money Earning the Best Possible Rate? (Sponsor)

Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.

However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.

There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.